Responses
Late breaking abstracts
Ovarian cancer
978 Concordance of the FDA-approved companion diagnostic and a next-generation sequencing assay kit for assessing homologous recombination deficiency in ovarian cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.